CBD reduced the negative emotional effects of opioid withdrawal in rats through serotonin receptors | Research

The takeaway

CBD blocked the development of conditioned place aversion during naloxone-triggered morphine withdrawal in rats, and this effect depended on 5-HT1A serotonin receptor activation.

Addiction researchers, neuroscientists, clinicians treating opioid use disorder, and those following CBD research for substance use disorders.

CBD at 5 and 20 mg/kg blocked withdrawal-induced place aversion via 5-HT1A receptors

What the researchers found

CBD (5 and 20 mg/kg) prevented conditioned place aversion induced by naloxone-precipitated morphine withdrawal. Pre-treatment with a 5-HT1A antagonist (WAY100635) blocked this effect, indicating serotonin receptor involvement.

Why it matters

Opioid withdrawal creates powerful negative emotional memories that drive relapse. If CBD can reduce the aversive quality of withdrawal through serotonin pathways, it could complement existing addiction treatments.

The numbers in context

CBD doses of 5 and 20 mg/kg attenuated conditioned place aversion. 5-HT1A antagonist WAY100635 reversed the CBD effect, confirming serotonin receptor involvement.

How the study worked

Conditioned place aversion paradigm in rats. Animals received morphine for dependence, then naloxone to trigger withdrawal paired with a specific compartment. CBD was administered before withdrawal sessions. 5-HT1A antagonist used to test mechanism.

What this study cannot tell us

Animal study with no direct human applicability. Conditioned place aversion is a behavioral proxy for withdrawal discomfort, not a direct measure. Doses and routes of CBD administration in rats do not translate directly to human dosing.

How to read the evidence

Well-designed animal study with mechanistic investigation. However, animal findings frequently do not translate to human outcomes.

When this study was published

Published 2022.

The bigger picture

The opioid crisis continues to claim lives, and existing medications for opioid use disorder, while effective, are underutilized and stigmatized. Non-opioid treatments that address the emotional dimensions of withdrawal could expand the therapeutic toolkit.

Questions still open

Would CBD produce similar effects during natural (non-naloxone-precipitated) opioid withdrawal? Can these findings be replicated in human clinical trials of opioid dependence?

Common questions

Could CBD help people going through opioid withdrawal?

This rat study provides a biological rationale for how CBD might reduce the emotional distress of opioid withdrawal. Some early human studies have also explored CBD for opioid cravings. However, animal results often do not translate to clinical practice, and much more human research is needed.

What is conditioned place aversion?

It is a laboratory test where an animal learns to avoid a location associated with an unpleasant experience (in this case, opioid withdrawal). If CBD prevents this avoidance learning, it suggests the withdrawal experience was perceived as less unpleasant.

Read the original research

Cannabidiol attenuates the expression of conditioned place aversion induced by naloxone-precipitated morphine withdrawal through the activation of 5-HT1A receptors.

Behavioural brain research, 450, 114504

View on PubMed ↗Publisher’s paper ↗

Citation

Souza, Adriana Jesus; Guimarães, Francisco S; Gomes, Felipe V. (2023). Cannabidiol attenuates the expression of conditioned place aversion induced by naloxone-precipitated morphine withdrawal through the activation of 5-HT1A receptors.. Behavioural brain research, 450, 114504. https://doi.org/10.1016/j.bbr.2023.114504